drugset / Trial / NCT00726505
Renal Mechanism of Action/Splay vs. TmG
RandomizedParallel-groupOpen-labelDiagnostic
Summary
The purpose of this study is to evaluate the effects of dapagliflozin to promote glucose loss in urine in healthy subjects and subjects with type 2 diabetes mellitus
Timeline
- Start
- 2009-06
- Primary completion
- 2009-08
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dapagliflozin | Small molecule | 5 mg | Oral |
| Comparator | Dapagliflozin | Small molecule | 20 mg | Oral |